Marshall Wace North America’s Doximity DOCS Stock Holding History

Marshall Wace North America’s Portfolio DOCS Stock Details DOCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-54,472	Closed	-$3.17M	–	1492
2021 Q2	$3.17M	Buy	+54,472	New	+$3.06M	0.01%	671

Other funds holding DOCS

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WRCM

Whale Rock Capital Management Boston, Massachusetts $12.5B AUM 306.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

ESCM

Echo Street Capital Management New York $747M AUM 24.25% 1-Year Est. Return

Marshall Wace North America's DOCS Position: Q3 2021 in Review

Marshall Wace North America sold out of Doximity (DOCS) in Q3 2021, closing a stake of 54,472 shares — an estimated $3.17M sold.

Marshall Wace North America first reported a position in DOCS in Q2 2021 and held it in 1 quarter. The position peaked at $3.17M in Q2 2021. 143 funds tracked by Wall St. Rank hold DOCS as of Q3 2021.

Marshall Wace North America reported no remaining Doximity position as of Q3 2021 after selling out during the quarter.
Marshall Wace North America sold 54,472 Doximity shares in Q3 2021, an estimated $3.17M.
Marshall Wace North America first reported a position in Doximity in Q2 2021 and held it in 1 quarter.
Marshall Wace North America's Doximity position peaked at $3.17M in Q2 2021.
143 funds tracked by Wall St. Rank held Doximity as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.